Evaluating the Efficacy and Safety of Teprotumumab N01 in Patients With Thyroid Eye Disease.
Clinical trial NCT07423013 · RECRUITING
Trial details
- NCT number
- NCT07423013
- Sponsor
- Peking University Third Hospital
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-11
- Primary completion
- 2026-12-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.